中新赛克（002912）公告，股东广东红土、昆山红土、南京红土、郑州百瑞合计持有公司股份957.76万 股，占公司总股本比例5.61%。上述股东计划通过集中竞价和大宗交易方式合计减持不超过512.25万 股，占总股本比例3%。减持将在公告披露15个交易日后的3个月内进行，集中竞价减持不超过总股本 1%，大宗交易减持不超过总股本2%。减持原因系创业投资基金退出需求。减持价格将根据市场价格确 定，且不低于公司发行价和最近一期经审计每股净资产。公司控股股东与减持股东为一致行动人。 ...

蓝箭电子（301348）公告，持股5%以上股东上海银圣宇企业管理咨询合伙企业计划在公告披露之日起 15个交易日后的三个月内以集中竞价方式减持不超过200万股，占公司总股本1%。董事、总经理袁凤江 拟减持不超过38.89万股，占公司总股本0.19%。董事、副总经理、财务总监赵秀珍拟减持不超过48.96 万股，占公司总股本0.24%。董事、副总经理、董事会秘书张国光拟减持不超过25.83万股，占公司总股 本0.13%。监事李永新拟减持不超过23.78万股，占公司总股本0.12%。减持原因均为股东自身资金需 求。 ...

中国经济网北京5月7日讯森霸传感（300701）(300701.SZ)昨日晚间披露实际控制人之一致行动人减持计划期限届满暨实施结果的公告。 | 股东名称 | 減持方式 | 减持时间 | 减持均价 | 减持股数 | 减持比例 | | --- | --- | --- | --- | --- | --- | | | | | (元/股) | (股) | (%) | | 康腾 8 号 | 集中竞价交易 | 2025/3/26- | 10.7400- | 521,500 | 0.1844 | | | (含盘后定价) | 2025/3/27 | 10.9400 | | | | 康腾 8 号 | 大宗交易 | 2025/2/20- | 9.4400 - | 1,791,570 | 0.6337 | | | | 2025/4/1 | 10.2800 | | | | N. V.T. | 集中竞价交易 | 2025/2/14- | 10.1100- | | | 森霸传感表示，康腾8号、单颖属于公司实际控制人单森林之一致行动人，减持计划的实施不会导致公司控制权发生变更，也不会对公司的治理结构及持 续经营产生重大影响。 2025年第一 ...

中国经济网北京5月7日讯迦南智能（300880）(300880.SZ)昨日晚间发布关于公司实际控制人之一致行动人减持股份预披露的公告。 公司于近日收到公司实际控制人之一致行动人宁波鼎耀企业管理合伙企业(有限合伙)(以下简称"鼎耀合伙")及公司实际控制人之一致行 动人周小玲、周月芬、周森月、何利荣提交的《关于股份减持计划的告知函》。 公司实际控制人章国耀、章恩友之一致行动人鼎耀合伙(原"宁波杭州湾新区鼎耀企业管理合伙企业(有限合伙)")系公司员工持股平台， 持有公司股份36,007,200股(占本公司总股本比例18.4522%)，计划在公告披露之日起15个交易日后的3个月内以集中竞价方式减持股份 数量不超过1,441,589股，减持比例不超过公司股份总数的0.7388%。 公司实际控制人章国耀、章恩友之亲属周小玲、周月芬、周森月、何利荣，构成公司实际控制人的一致行动人，分别持有公司股份 960,192股、240,048股、120,024股、120,024股，持股比例分别为0.4921%、0.1230%、0.0615%、0.0615%，计划在公告披露之日起15个 交易日后的3个月内以集中竞价方式减持股份数量合计不 ...

中国经济网北京5月6日讯中微公司(688012.SH)昨晚发布董监高集中竞价减持股份计划公告。中微公司 于近日收到尹志尧、陈伟文分别出具的《减持意向书》，因个人资金需求，上述减持主体计划自公告披 露之日起15个交易日后的3个月内，在符合法律法规规定的减持前提下，通过集中竞价等方式减持公司 股份。 尹志尧计划减持公司股份数量不超过280,000股，占公司总股本比例0.045%。陈伟文计划减持公司股份 数量不超过125,000股，占公司总股本比例0.020%。 截至公告披露日，中微公司董事长、总经理尹志尧直接持有公司股份4,329,436股，占公司总股本的 0.696%；公司财务负责人、副总经理陈伟文直接持有公司股份500,000股，占公司总股本的0.080%。上 述股份为公司首次公开发行前持有的股份。 中微公司的保荐机构(主承销商)是海通证券股份有限公司(现名"国泰海通证券股份有限公司")，保荐代 表人是吴志君、姜诚君；长江证券承销保荐有限公司任联席主承销商。中微公司IPO发行费用总额为 10,593.26万元，其中保荐及承销费用8,782.84万元。 此外，公司2020年度向特定对象发行A股股票募集资金。中国 ...

Group 1 - The shareholders Qingdao Jinshi and Changxia Jinshi plan to reduce their holdings in Airo Energy by up to 800,000 shares each, representing 0.50% of the total share capital, within three months after 15 trading days from the announcement [1][2] - Shanghai Zhongdian Investment plans to reduce its holdings by up to 1,600,000 shares, which is 1% of the total share capital, within the same timeframe [1][2] - The total number of shares to be reduced by all shareholders amounts to 3,200,000 shares, which does not affect the control of the listed company [2] Group 2 - As of the announcement date, Qingdao Jinshi and Changxia Jinshi each hold 4,562,520 shares, accounting for 2.85% of the total share capital, with specific shares becoming tradable on January 3, 2025, and May 6, 2025 [2] - Shanghai Zhongdian holds 6,388,320 shares, representing 3.99% of the total share capital, with the same tradable dates as above [2] - Airo Energy was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 3, 2024, with an initial public offering price of 55.66 yuan per share, and is currently in a state of price decline [2] Group 3 - Airo Energy raised a total of 2,226.40 million yuan from its initial public offering, with a net amount of 1,988.07 million yuan after deducting issuance costs, exceeding the original plan by 1,179.35 million yuan [3] - The funds raised are intended for projects including the expansion of energy storage batteries and inverters, the construction of a smart energy R&D center, and the establishment of an overseas marketing and service system [3] - The total issuance costs amounted to 238.33 million yuan, with underwriting fees constituting a significant portion [3]

Core Points - Gannee Pharmaceutical (甘李药业) announced the completion of a share reduction plan by its shareholder, Beijing Xutong Hongda Technology Co., Ltd. (旭特宏达), which reduced its holdings by 6,010,622 shares, representing 1% of the company's total share capital [1][2] - The share reduction occurred between April 22, 2025, and April 30, 2025, with a price range of 44.85 to 49.81 yuan per share, totaling approximately 290.35 million yuan [1][2] - After the reduction, Xutong Hongda holds 35,473,235 shares, accounting for 5.90% of the total share capital [2] Shareholder Information - Before the reduction, Xutong Hongda and its concerted party, Gan Zhongru, held a combined total of 247,127,614 shares, which is 41.11% of the total share capital [3] - Xutong Hongda owned 41,483,857 shares (6.90%), while Gan Zhongru held 205,643,757 shares (34.21%) [3] - Gan Zhongru is the largest shareholder of Gannee Pharmaceutical, and Xutong Hongda is the second largest [3] Fundraising Activities - Gannee Pharmaceutical went public on June 29, 2020, raising a total of 2.545 billion yuan, with a net amount of 2.441 billion yuan after expenses [4] - The funds raised were allocated for various projects, including marketing network construction and product registration in the U.S. [4] - In 2023, the company issued 28,508,550 shares at a price of 27.12 yuan per share, raising approximately 773.15 million yuan, with a net amount of about 759.73 million yuan after expenses [5]

Group 1 - The major shareholder, Zhejiang Chuchu Equity Investment Partnership, plans to reduce its stake in Chuhuan Technology by up to 2,395,605 shares, representing 3% of the total share capital after excluding repurchased shares, within three months starting from May 27, 2025 [1] - The reduction will occur through a combination of centralized bidding and block trading, with a maximum of 798,535 shares to be sold via centralized bidding and 1,597,070 shares via block trading [1] - Chuhuan Technology assures that this reduction will not lead to a change in control or affect the company's governance structure and ongoing operations [1] Group 2 - In Q1 2025, Chuhuan Technology reported revenue of 24.23 million yuan, a year-on-year decrease of 74.05%, and a net profit attributable to shareholders of 3.90 million yuan, down 57.18% [2] - The company's cash flow from operating activities was 20.26 million yuan, compared to 11.41 million yuan in the same period last year [2] - Chuhuan Technology was listed on the Shenzhen Stock Exchange on July 25, 2022, raising a total of 460 million yuan, with net proceeds of 382.57 million yuan intended for various projects including air pollution control equipment production lines and a technology research center [3][4]

Group 1 - Major shareholders of *ST WanFang plan to reduce their holdings by up to 9,341,596 shares, accounting for 3% of the company's total share capital from May 27 to August 25, 2025 [1] - Shareholders of Airo Energy intend to reduce their holdings by up to 800,000 shares, 800,000 shares, and 1,600,000 shares, representing 0.50%, 0.50%, and 1% of the company's total share capital respectively during the same period [1] - Anner plans to reduce its holdings by up to 3,186,159 shares, which is 1.5% of the company's total share capital, from May 27 to August 26, 2025 [1] Group 2 - Shareholders of Chuhuan Technology plan to reduce their holdings by up to 2,395,605 shares, accounting for 3% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [1] - Major shareholder of Dalian Technology intends to reduce their holdings by up to 4,189,336 shares, which is 0.99% of the company's total share capital from May 27 to August 26, 2025 [2] - Dongwei Technology's board members plan to reduce their holdings by a total of 2,574,857 shares, representing 0.8629% of the company's total share capital during the same period [2] Group 3 - Gann Li Pharmaceutical's shareholder has completed a reduction of 6,010,622 shares, which is 1% of the company's total share capital from April 22 to April 30, 2025 [2] - Guanshi Technology's board members plan to reduce their holdings by up to 359,375 shares, accounting for 0.4891% of the company's total share capital from May 27 to August 26, 2025 [2] - Guoguang Electric's shareholder has completed a reduction of 1,625,751 shares, which is 1.5% of the company's total share capital from April 25 to April 30, 2025 [2] Group 4 - Haili Biological's major shareholder has completed a reduction of 13,113,244 shares, representing 2% of the company's total share capital from April 15 to April 22, 2025 [3] - Hengfeng Information's board member has completed a reduction of 198,717 shares, which is 0.1207% of the company's total share capital on April 28, 2025 [3] - Hongwei Technology's shareholder plans to reduce their holdings by up to 820,000 shares, accounting for 0.39% of the company's total share capital from May 12 to August 11, 2025 [3] Group 5 - Huatai Medical's vice president has completed a reduction of 29,943 shares, which is 0.0308% of the company's total share capital from April 28 to April 29, 2025 [4] - Jilin Carbon Valley's major shareholder has completed a reduction of 4,989,160 shares, representing 0.8490% of the company's total share capital from April 25 to April 29, 2025 [4] - Jiahua Technology's shareholder plans to reduce their holdings by up to 1,160,000 shares, accounting for 1.50% of the company's total share capital from May 28 to August 25, 2025 [4] Group 6 - Jiangbo Long's shareholder plans to reduce their holdings by up to 4,159,815 shares, which is 1% of the company's total share capital from May 27 to August 26, 2025 [5] - Jiangshan Co. plans to reduce its holdings in Jiangtian Chemical by 4,330,800 shares, accounting for 3% of its total share capital from May 27 to August 26, 2025 [5] - Kairun Co.'s major shareholder plans to reduce their holdings by up to 9,000,000 shares, representing 2.43% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [5] Group 7 - Lianqi Technology's shareholders plan to reduce their holdings by a total of 18,717,374 shares, which is 2.96% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [9] - Zhongke Information's board members have completed a reduction of 698,914 shares, representing 0.2358% of the company's total share capital [9] - Zhongshi Co.'s major shareholder plans to reduce their holdings by up to 1,800,000 shares, accounting for 1.1527% of the company's total share capital from May 27 to August 26, 2025 [10]

关于持股5%以上股东减持股份的预披露公告 持股5%以上股东安吉浙楚股权投资合伙企业（有限合伙）保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001336 证券简称：楚环科技 公告编号：2025-018 杭州楚环科技股份有限公司 特别提示： 持有杭州楚环科技股份有限公司（以下简称"公司"或"本公司"）股份4,991,578股（占剔除公司回购专用 证券账户股份后的总股本的6.25%）的大股东安吉浙楚股权投资合伙企业（有限合伙）（以下简称"浙 楚投资"）计划自本公告披露日起15个交易日后的3个月内（即2025年5月27日至2025年8月26日），以集 中竞价交易方式、大宗交易方式合计减持本公司股份不超过2,395,605股（占剔除公司回购专用证券账户 股份后的总股本的3%）。其中，以集中竞价交易方式减持股份数量不超过798,535股（即不超过剔除公 司回购专用证券账户股份后的总股本的1%），以大宗交易方式减持股份数量不超过1,597,070股（即不 超 ...